Press Releases

National Brain Tumor Society Statement on 5th Annual Congressional Glioblastoma Awareness Day Resolution In anticipation of the 5th anniversary of Glioblastoma Awareness Day, the National Brain Tumor Society has once again worked with a bipartisan group of U.S. Senators and Representatives to introduce a congressional resolution designating Wednesday, July 19, as a day to raise public awareness for this highly aggressive and deadly form of brain cancer. In […] May 18, 2023

World Class Hospitals Join DNA Damage Response Consortium to Bring Forward New Treatments for Adults and Children with Brain Cancer Researchers from St. Jude Children’s Research Hospital, NYU, UCSF, and the University of Minnesota join National Brain Tumor Society and Yale-led Initiative   Today, the National Brain Tumor Society (NBTS), in partnership with Yale Cancer Center, announced new partners for its DNA Damage Response Consortium. Joining the initiative are world-class experts in adult and pediatric neuro-oncology […] March 28, 2023

National Brain Tumor Society Statement on 2023 State of the Union Address National Brain Tumor Society (NBTS), the nation’s largest nonprofit dedicated to defeating brain tumors and improving the lives of patients with brain tumors, commends President Joe Biden for continuing to put cancer patients and cancer research at the forefront of the national public policy discussion.  During his 2023 State of the Union address, the president […] February 8, 2023

NBTS and IQVIA Announce Collaboration to Support DNA Damage Repair Research and Treatment Development in Brain Tumors National Brain Tumor Society (NBTS), the nation’s largest nonprofit dedicated to defeating brain tumors and improving the quality of brain tumor patients’ lives, and IQVIA, a leading global provider of advanced analytics, technology solutions, and clinical research services, have announced a collaboration through IQVIA Biotech to support the development of DNA Damage Repair inhibitors for […] November 15, 2022

Brain Tumor Patient Advocacy Organizations Team Up to Advance Novel Imaging Framework to Evaluate Drug Efficacy Grant to UCLA researchers will validate an imaging-based clinical trial endpoint to better enable decision-making in brain tumor drug development  Today, the National Brain Tumor Society (NBTS), the nation’s largest nonprofit dedicated to defeating brain tumors and improving the lives of patients with brain tumors, and The Sontag Foundation, one of the largest private funders […] October 6, 2022